At the beginning of the New Year, Vientiane was updated. At 8 a.m. on January 6, 2021, the relocation and unveiling ceremony of Fujian Haixi New Pharmaceutical Creation Co., Ltd. was grandly held at the new venue. Deputy Director Zhong Zhimin of Cangshan District, Fuzhou City, Director Yan Wu of Cangshan District Bureau of Industry and Information Technology, representatives of the company's shareholder units, all employees of the company, and relevant enterprises and media attended the ceremony.
Deputy District Director Zhong Zhimin, Director Yan Wu, Chairman Kang Xinshan and shareholders' representatives of the company jointly unveiled the company.
Huang Lifeng, former chairman of the company and chairman of the Provincial Pharmaceutical Management Group, congratulated the company on the relocation of the new site and the unveiling ceremony of Haixi New Drug Research and Development and Transformation Center. He said that in the past few years, he has witnessed the arduous entrepreneurial process of Haixi New Medicine from scratch, from childhood to large, and also witnessed the responsibility of Haixi New Medicine to unite, pragmatically and strive hard. In the future, we will continue to support the development of the company and help the enterprise grow rapidly.
Zhong Zhimin, deputy director of Cangshan District, Fuzhou City, pointed out in his speech that Haixi New Medicine, as a key unit for the development of the biomedical industry in Cangshan District, has worked silently since its establishment and is committed to realizing the beautiful vision of allowing Chinese people to use the best drugs. With the joint efforts of Dr. Kang Xinshan's team, it has made remarkable achievements in the research and development of generic drugs and innovative drugs, making outstanding contributions to improving the research level of the biomedical industry in Fujian Province. This time, the landing and unveiling of Haixi New Drug Research and Development and Transformation Center is a major initiative of a strong alliance of government and enterprises, and it is also of great significance to enhance the company's influence. It is hoped that the center can focus on the development needs of biomedical industrialization, give full play to the synergy of talents, scientific research and achievement transformation, strive to build a first-class industrial research and development platform, and provide strong support for the leapfrog development of the biomedical industry in Cangshan District and even Fuzhou and Fujian Province.
Dr. Kang Xinshan, chairman and president of the company, said in his speech that 2020 is a milestone year for the company, and today's opening ceremony is also a milestone event in the company's development history. We will take the company's inauguration as an opportunity to implement the company's development strategic plan, stand at a new starting point, actively promote various R&D business work, effectively improve the level of enterprise management, and continuously improve our innovation ability and technical level. Work together to innovate and actively explore new ways, new ideas, new measures and mechanisms for the company's development in a new market environment, and strive to build the company into a domestic and even international first-class science and development enterprise.
After the ceremony, the leaders and guests also visited the company's new R&D office.
